|
|
Volumn 94, Issue 10, 2000, Pages 948-953
|
|
Fenoterol hydrobromide delivered via HFA-MDI or CFC-MDI in patients with asthma: A safety and efficacy comparison
a
b
c
|
|
Author keywords
Asthma; CFC MDI; Fenoterol; HFA MDI; Metered dose inhaler
|
|
Indexed keywords
ANTIHISTAMINIC AGENT;
ASTEMIZOLE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CHLOROFLUOROCARBON;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
FENOTEROL;
FLUORINATED HYDROCARBON;
PROPELLANT;
SALBUTAMOL;
THEOPHYLLINE;
ADULT;
AGED;
ARTICLE;
ASTHMA;
BLOOD PRESSURE MEASUREMENT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERABILITY;
ELECTROCARDIOGRAM;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
INCIDENCE;
LABORATORY TEST;
LONG TERM CARE;
LUNG FUNCTION TEST;
MAJOR CLINICAL STUDY;
MALE;
METERED DOSE INHALER;
MULTICENTER STUDY;
PEAK EXPIRATORY FLOW;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
PULSE RATE;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT DISEASE;
|
|
EID: 0033759598
PISSN: 09546111
EISSN: None
Source Type: Journal
DOI: 10.1053/rmed.2000.0864 Document Type: Article |
|
Times cited : (6)
|
|
References (14)
|
